Ilaria Giardini

578 total citations
22 papers, 365 citations indexed

About

Ilaria Giardini is a scholar working on Hematology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Ilaria Giardini has authored 22 papers receiving a total of 365 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 7 papers in Molecular Biology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Ilaria Giardini's work include Acute Myeloid Leukemia Research (16 papers), Acute Lymphoblastic Leukemia research (5 papers) and Lymphoma Diagnosis and Treatment (5 papers). Ilaria Giardini is often cited by papers focused on Acute Myeloid Leukemia Research (16 papers), Acute Lymphoblastic Leukemia research (5 papers) and Lymphoma Diagnosis and Treatment (5 papers). Ilaria Giardini collaborates with scholars based in Italy and Belgium. Ilaria Giardini's co-authors include Marina Boni, Paolo Bernasconi, Marilena Caresana, Barbara Rocca, Paola Maria Cavigliano, Silvia Calatroni, Mario Lazzarino, Rita Zappatore, Catherine Klersy and Carlo Bernasconi and has published in prestigious journals such as Blood, Annals of the New York Academy of Sciences and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Ilaria Giardini

21 papers receiving 352 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ilaria Giardini Italy 11 265 137 87 50 49 22 365
J.G. Fuzibet France 9 155 0.6× 61 0.4× 83 1.0× 83 1.7× 26 0.5× 37 341
Philippe Agapé France 10 276 1.0× 130 0.9× 88 1.0× 35 0.7× 23 0.5× 20 378
Toshiro Kawakita Japan 11 319 1.2× 91 0.7× 90 1.0× 118 2.4× 22 0.4× 77 504
Sigrid Machherndl‐Spandl Austria 8 159 0.6× 63 0.5× 87 1.0× 30 0.6× 25 0.5× 36 248
M A Kharfan-Dabaja United States 10 235 0.9× 47 0.3× 50 0.6× 64 1.3× 17 0.3× 24 322
Wolfgang Hill Germany 7 139 0.5× 119 0.9× 38 0.4× 24 0.5× 22 0.4× 20 331
R. M. Stone United States 9 189 0.7× 60 0.4× 129 1.5× 45 0.9× 16 0.3× 13 304
M Vigier France 9 150 0.6× 120 0.9× 33 0.4× 35 0.7× 22 0.4× 12 326
Ikuo Miura Japan 9 194 0.7× 70 0.5× 67 0.8× 27 0.5× 14 0.3× 12 332
Alexandra Kolenová Slovakia 10 136 0.5× 35 0.3× 77 0.9× 122 2.4× 21 0.4× 40 332

Countries citing papers authored by Ilaria Giardini

Since Specialization
Citations

This map shows the geographic impact of Ilaria Giardini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilaria Giardini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilaria Giardini more than expected).

Fields of papers citing papers by Ilaria Giardini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ilaria Giardini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilaria Giardini. The network helps show where Ilaria Giardini may publish in the future.

Co-authorship network of co-authors of Ilaria Giardini

This figure shows the co-authorship network connecting the top 25 collaborators of Ilaria Giardini. A scholar is included among the top collaborators of Ilaria Giardini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ilaria Giardini. Ilaria Giardini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ferretti, Virginia Valeria, et al.. (2022). Effectiveness of a Reliable Toxicological Analysis for a Correct Diagnosis of Acute Intoxication in Pediatrics. Pediatric Emergency Care. 38(10). e1601–e1605. 2 indexed citations
2.
Decembrino, Nunzia, Katia Perruccio, Marco Zecca, et al.. (2019). A Case Series and Literature Review of Isavuconazole Use in Pediatric Patients with Hemato-oncologic Diseases and Hematopoietic Stem Cell Transplantation. Antimicrobial Agents and Chemotherapy. 64(3). 39 indexed citations
3.
Molinaro, Mariadelfina, Paola Morelli, Manuela De Gregori, et al.. (2018). Efficacy of intraventricular amikacin treatment in pan-resistant <em>Pseudomonas aeruginosa</em> postsurgical meningitis. Infection and Drug Resistance. Volume 11. 1369–1372. 12 indexed citations
4.
Invernizzi, Rosangela, Marina Boni, Rita Zappatore, et al.. (2017). MDS/AML del(11)(q14) Share Common Morphological Features Despite Different Chromosomal Breakpoints. Anticancer Research. 37(2). 645–650. 1 indexed citations
5.
Rocca, Barbara, Catherine Klersy, Rita Zappatore, et al.. (2017). Alternative splicing of hTERT: a further mechanism for the control of active hTERT in acute myeloid leukemia. Leukemia & lymphoma. 59(3). 702–709. 6 indexed citations
6.
Boni, Marina, Marianna Rossi, Patrizia Zappasodi, et al.. (2012). Detection of TET2 abnormalities by fluorescence in situ hybridization in 41 patients with myelodysplastic syndrome. Cancer Genetics. 205(6). 285–294. 4 indexed citations
7.
Bernasconi, Paolo, Catherine Klersy, Barbara Rocca, et al.. (2012). Human Telomerase Reverse Transcriptase (hTERT): A New Potential Prognostic Marker in AML?. Blood. 120(21). 4790–4790.
8.
Bernasconi, Paolo, Catherine Klersy, Marina Boni, et al.. (2010). Does cytogenetic evolution have any prognostic relevance in myelodysplastic syndromes? A study on 153 patients from a single institution. Annals of Hematology. 89(6). 545–551. 16 indexed citations
9.
Orlandi, Ester, Silvia Zibellini, Cristiana Pascutto, et al.. (2009). IGHV Unmutated Status Influences Outcome More Than IGHV1-69 Gene Usage Per Se in Patients With Chronic Lymphocytic Leukemia. Clinical Lymphoma & Myeloma. 9(5). 390–393. 4 indexed citations
10.
Klersy, Catherine, Marina Boni, Paola Maria Cavigliano, et al.. (2007). Has Cytogenetic Evolution Any Prognostic Relevance in Myelodysplastic Syndromes (MDS)? A Study on 153 Patients.. Blood. 110(11). 2460–2460. 1 indexed citations
11.
Bernasconi, Paolo, Catherine Klersy, Marina Boni, et al.. (2007). World Health Organization classification in combination with cytogenetic markers improves the prognostic stratification of patients with de novo primary myelodysplastic syndromes. British Journal of Haematology. 137(3). 193–205. 64 indexed citations
12.
Bernasconi, Paolo, Marina Boni, Paola Maria Cavigliano, et al.. (2007). Prognostic Significance of EVI1 Defects in MDS/AML with 3q21q26 Abnormalities.. Blood. 110(11). 4224–4224. 1 indexed citations
13.
Bernasconi, Paolo, Marina Boni, Paola Maria Cavigliano, et al.. (2006). Clinical Relevance of Cytogenetics in Myelodysplastic Syndromes. Annals of the New York Academy of Sciences. 1089(1). 395–410. 25 indexed citations
14.
Bernasconi, Paolo, Silvia Calatroni, Ilaria Giardini, et al.. (2005). ABL1 amplification in T-cell acute lymphoblastic leukemia. Cancer Genetics and Cytogenetics. 162(2). 146–150. 17 indexed citations
15.
Bernasconi, Paolo, Catherine Klersy, Marina Boni, et al.. (2005). Incidence and prognostic significance of karyotype abnormalities in de novo primary myelodysplastic syndromes: a study on 331 patients from a single institution. Leukemia. 19(8). 1424–1431. 59 indexed citations
16.
Bernasconi, Paolo, Marina Boni, Paola Maria Cavigliano, et al.. (2004). Molecularly Targeted Therapy in Acute Myeloid Leukemia. Annals of the New York Academy of Sciences. 1028(1). 409–422. 8 indexed citations
17.
Bernasconi, Paolo, Paola Maria Cavigliano, Marina Boni, et al.. (2003). Is FISH a relevant prognostic tool in myelodysplastic syndromes with a normal chromosome pattern on conventional cytogenetics? A study on 57 patients. Leukemia. 17(11). 2107–2112. 47 indexed citations
18.
Bernasconi, Paolo, Marina Boni, Paola Maria Cavigliano, et al.. (2002). Molecular Genetics of Acute Myeloid Leukemia. Annals of the New York Academy of Sciences. 963(1). 297–305. 9 indexed citations
19.
Bernasconi, Paolo, Paola Maria Cavigliano, Marina Boni, et al.. (2002). Long‐term follow up with conventional cytogenetics and band 13q14 interphase/metaphase in situ hybridization monitoring in monoclonal gammopathies of undetermined significance. British Journal of Haematology. 118(2). 545–549. 12 indexed citations
20.
Bernasconi, Paolo, Marina Boni, Silvia Calatroni, et al.. (2002). Acute myeloid leukemia (AML) having evolved from essential thrombocythemia (ET): distinctive chromosome abnormalities in patients treated with pipobroman or hydroxyurea. Leukemia. 16(10). 2078–2083. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J.G. Fuzibet Breakdown of academic impact, for papers by Philippe Agapé Breakdown of academic impact, for papers by Toshiro Kawakita Breakdown of academic impact, for papers by Sigrid Machherndl‐Spandl Breakdown of academic impact, for papers by M A Kharfan-Dabaja Breakdown of academic impact, for papers by Wolfgang Hill Breakdown of academic impact, for papers by R. M. Stone Breakdown of academic impact, for papers by M Vigier Breakdown of academic impact, for papers by Ikuo Miura Breakdown of academic impact, for papers by Alexandra Kolenová
Rankless by CCL
2026